A groundbreaking platform developed by researchers at Tel Aviv University utilizes polymeric nanoparticles to deliver paired drugs directly to specific cancer types, maximizing therapeutic effects while minimizing harm to healthy tissues.
Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to specific cancer types, including skin cancer and breast cancer. The researchers explain that having both drugs arrive at the tumor site together significantly amplifies their therapeutic effects and safety profiles. The study was led by Prof.
Ronit Satchi-Fainaro and doctoral student Shani Koshrovski-Michael from the Department of Physiology and Pharmacology at Tel Aviv University's School of Medicine, in collaboration with other members of Prof. Satchi-Fainaro's lab: Daniel Rodriguez Ajamil, Dr. Pradip Dey, Ron Kleiner, Dr. Yana Epshtein, Dr. Marina Green Buzhor, Rami Khoury, Dr. Sabina Pozzi, Gal Shenbach-Koltin, Dr. Eilam Yeini, and Dr. Rachel Blau. They were joined by Prof. Iris Barshack from the Department of Pathology at Tel Aviv University's School of Medicine, Prof. Roey Amir and Shahar Tevet from the School of Chemistry at Tel Aviv University, and researchers from the Israel Institute of Biological Research, Italy, Portugal, and the Netherlands. The study was published in the prestigious journal Science Advances. Prof. Satchi-Fainaro explains: 'Currently, cancer treatment often involves a combination of multiple drugs that work synergistically to enhance their anti-cancer effect. However, these drugs differ in their chemical and physical properties – such as their rate of degradation, their circulation time in the bloodstream, and their ability to penetrate and accumulate in the tumor. Therefore, even if multiple drugs are administered simultaneously, they don't arrive together at the tumor, and their combined effects are not fully realized. To ensure maximal efficacy and minimal toxicity, we sought a way to deliver two drugs simultaneously and selectively to the tumor site without harming healthy organs
CANCER TREATMENT NANOPARTICLES DRUG DELIVERY TEL AVIV UNIVERSITY RESEARCH
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Hezbollah fires massive '340 missile' barrage in Tel Aviv after Israel killed 29 in LebanonHezbollah has fired 340 missiles into Tel Aviv and struck the Ashdod military base 'for the first time', reports claim.
Read more »
Beşiktaş vs Maccabi Tel Aviv: UEFA Europa League stats & head-to-headFollow live text commentary, score updates and match stats from Beşiktaş vs Maccabi Tel Aviv in the UEFA Europa League
Read more »
Leeds United Show Interest in Maccabi Tel Aviv's Dor TurgemanLeeds United are reportedly considering a move for Maccabi Tel Aviv striker Dor Turgeman ahead of the January transfer window. The club has made official inquiries about the player's availability, though Maccabi Tel Aviv may prefer to retain him until the end of the season.
Read more »
Maccabi Tel Aviv vs Rīgas FS: UEFA Europa League stats & head-to-headFollow live text commentary, score updates and match stats from Maccabi Tel Aviv vs Rīgas FS in the UEFA Europa League
Read more »
16 injured after rocket fired from Yemen hits Tel AvivThe attack comes less than two days after a series of Israeli air strikes on Yemen’s Houthi rebel-held capital Sanaa and port city of Hodeida.
Read more »
University of South Florida Researchers Publish Guide to Credible Podcasts on Infectious DiseasesA research team at the University of South Florida has published a study on credible podcasts for infectious diseases, addressing the challenge of disseminating accurate health information in the digital age.
Read more »